Japan Faces 15 Percent Pharma Tariffs Under Trump Section 232 While Auto Sector Remains Protected Through Trade Deal

Welcome to Japan Tariff News and Tracker, listeners. As of mid-April 2026, President Trump's tariff landscape continues to evolve, with Japan squarely in focus amid global trade shifts. Baker Botts' Trump Tariff Tracker from April 13 reports that U.S. imports from Japan face a 15% ad valorem duty on patented pharmaceuticals and ingredients under the new Section 232 proclamation issued April 2. This reduced rate—compared to 100% for others—applies to products from Japan, the EU, Korea, Switzerland, and Liechtenstein, effective July 31 for listed companies and September 29 for all others. JD Supra confirms this targets active pharmaceutical ingredients and key materials, sparing generics and U.S.-origin drugs, as part of national security measures. Broader tariffs provide context: ISM notes average U.S. rates have stabilized around 10% since Liberation Day last year, imposed via Section 122 after the Supreme Court struck down IEEPA tariffs. Japan benefits from no country-specific escalations, unlike proposed 50% hikes elsewhere, per the tracker. An Executive Order implemented a U.S.-Japan Trade Deal, modifying reciprocal tariffs and offering Japan carve-outs in autos and steel—25% on imports but with USMCA-style allowances. These moves signal Trump's strategy to pressure supply chains away from China, boosting Japan as a key partner. ISM highlights Southeast Asia and Mexico gaining, but Japan's pharma and auto sectors hold steady with favorable rates. Treasury Secretary Scott Benson indicated in Bloomberg reports that Section 301 studies could restore higher levies by July, potentially impacting Japan if excess capacity probes expand. Listeners, stay ahead of these shifts affecting Japanese exports. Thank you for tuning in—subscribe for weekly updates. This has been a Quiet Please production, for more check out quietplease.ai. For more check out https://www.quietperiodplease.com/ Avoid ths tariff fee's and check out these deals https://amzn.to/4iaM94Q This content was created in partnership and with the help of Artificial Intelligence AI.